The role of α-tocopherol in preventing disease

European Journal of Nutrition

Volumn 43, Issue SUPPL. 1, 2004, Pages

  Azzi, Angelo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

tocopherol; Atherosclerosis; CHD; Vitamin E metabolism

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; CELL ADHESION MOLECULE; CYTOKINE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; PROTEIN KINASE C; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR CD36; SUPEROXIDE; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CELL PROLIFERATION; CELL TYPE; CLINICAL TRIAL; CYTOKINE PRODUCTION; ENZYME INHIBITION; FIBROBLAST; FOAM CELL; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; LIPID OXIDATION; MACROPHAGE; MESANGIUM CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; THROMBOCYTE AGGREGATION INHIBITION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; VITAMIN SUPPLEMENTATION;

ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; ARTERIES; ARTERIOSCLEROSIS; CONTROLLED CLINICAL TRIALS; DIET; HUMANS; PLATELET ADHESIVENESS; PLATELET AGGREGATION; PREVENTIVE MEDICINE; VITAMIN E;

ANIMALIA;

EID: 3142707998     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Ozer NK, Sirikci O, Taha S, San T, Moser U, Azzi A (1998) Effect of vitamin E and probucol on dietary cholesterol-induced atherosclerosis in rabbits. Free Radic Biol Med 24:226-233
2. Ribeiro Jorge PA, Neyra LC, Ozaki RM, Almeida E de (1998) Improvement in the endothelium-dependent relaxation in hypercholesterolemic rabbits treated with vitamin E. Atherosclerosis 140: 333-339
3. Williams MA, Belcaro G, Szendro G, Nicolaides AN (1992) Duplex scanning evaluation of internal carotid stenosis. Improved detection of early lesions. Panminerva Med 34:49-54
4. Keaney JF Jr, Gaziano JM, Xu A, Frei B, Curran-Celentano J, Shwaery GT, Loscalzo J, Vita JA (1994) Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 93: 844-851
5. Terasawa Y, Ladha Z, Leonard SW, Morrow JD, Newland D, Sanan D, Packer L, Traber MG, Farese RV Jr (2000) Increased atherosclerosis in hyperlipidemic mice deficient in alpha-tocopherol transfer protein and vitamin E. Proc Natl Acad Sci USA 97:13830-13834
6. Verlangieri AJ, Bush MJ (1992) Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11:131-138
7. Benson GM, Schiffelers R, Nicols C, Latcham J, Vidgeon-Hart M, Toseland CD, Suckling KE, Groot PH (1998) Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice. Atherosclerosis 141:237-247
8. Witting PK, Mohr D, Stocker R (1999) Assessment of prooxidant activity of vitamin E in human low-density lipoprotein and plasma. Methods Enzymol 299:362-375
9. Ben Hamida C, Doerflinger N, Belal S, Linder C, Reutenauer L, Dib C, Gyapay G, Vignal A, Le Paslier D, Cohen D, et al. (1993) Localization of Friedreich ataxia phenotype with selective vitamin E deficiency to chromosome 8q by homozygosity mapping (see comments). Nat Genet 5:95-200
10. Benomar A, Yahyaoui M, Marzouki N, Birouk N, Bouslam N, Belaidi H, Amarti A, Ouazzani R, Chkili T (1999) Vitamin E deficiency ataxia associated with adenoma. J Neurol Sci 162:97-101
11. Labauge P, Cavalier L, Ichalalene L, Castelnovo G (1998) Friedreich's ataxia and hereditary vitamin E deficiency. Case study. Rev Neurol (Paris) 154: 339-341
12. Keaney JF Jr, Simon DI, Freedman JE (1999) Vitamin E and vascular homeostasis: implications for atherosclerosis. Faseb J 13:965-975
13. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4: 1189-1192
14. Sigounas G, Anagnostou A, Steiner M (1997) D1-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer 28:30-35
15. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E (1993) Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 57:787S-797S
16. Kardinaal AF, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodriguez M, et al. (1993) Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet 342:1379-1384
17. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444-1449
18. Hodis HN, Mack WJ, Barth J (1996) Carotid intima-media thickness as a surrogate end point for coronary artery disease. Circulation 94:2311-2312
19. Selzer RH, Hodis HN, Kwong-Fu H, Mack WJ, Lee PL, Liu CR, Liu CH (1994) Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 111:1-11
20. Bonithon-Kopp C, Coudray C, Berr C, Touboul PJ, Feve JM, Favier A, Ducimetiere P (1997) Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The EVA Study. Etude sur le Vieillisement Arteriel. Am J Clin Nutr 65:121-127
21. Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87:II56-65
22. Salonen JT, Nyyssonen K, Salonen R, Lakka HM, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Lakka TA, Rissanen T, Leskinen L, et al. (2000) Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 248:377-386
23. Blankenhorn DH, Johnson RL, Nessim SA, Azen SP, Sanmarco ME, Selzer, RH (1987) The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results. Control Clin Trials 8:356-387
24. Azen SP, Qian D, Mack WJ, Sevanian A, Selzer RH, Liu CR, Liu CH, Hodis HN (1996) Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94:2369-2372
25. Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K (2001) Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 103: 919-925
26. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347:781-786
27. Brown M (1999) Do vitamin E and fish oil protect against ischaemic heart disease? Lancet 354:441-442
28. Marchioli R (1999) Antioxidant vitamins and prevention of cardiovascular disease: laboratory, epidemiological and clinical trial data. Pharmacol Res 40:227-258
29. Jialal I, Devaraj S, Huet BA, Traber M (1999) GISSI-Prevenzione trial. Lancet 354:1554; discussion: 1556-1557
30. Ng W, Tse HF, Lau CP (1999) GISSI-Prevenzione trial. Lancet 354:1555-1556; discussion: 1556-1557
31. Salen P, de Lorgeril M (1999) GISSI-Prevenzione trial. Lancet 354:1555; discussion:1556-1557
32. Blot, WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, Yang CS, Zheng SF, Gail M, Li GY, etal. (1993) Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492
33. Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, et al. (1996) Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88:1560-1570
34. Heinonen OP, Albanes D, Virtamo J, Taylor PR, Huttunen JK, Hartman AM, Haapakoski J, Malila N, Rautalahti M, Ripatti S, et al. (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440-446
35. Virtamo J, Rapola JM, Ripatti S, Heinonen OP, Taylor PR, Albanes D, Huttunen JK (1998) Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med 158:668-675
36. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P (2000) Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342:154-160
37. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial (In Process Citation). Lancet 356: 1213-1218
38. Sattler W, Levak-Frank S, Radner H, Kostner GM, Zechner R (1996) Muscle-specific overexpression of lipoprotein lipase in transgenic mice results in increased alpha-tocopherol levels in skeletal muscle. Biochem J 318:15-19
39. Behrens WA, Thompson JN, Madere R (1982) Distribution of alpha-tocopherol in human plasma lipoproteins. Am J Clin Nutr 35:691-696
40. Kostner GM, Oettl K, Jauhiainen M, Ehnholm C, Esterbauer H, Dieplinger H (1995) Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem J 305: 659-667
41. Kolleck I, Schlame M, Fechner H, Looman AC, Wissel H, Rustow B (1999) HDL is the major source of vitamin E for type II pneumocytes. Free Radic Biol Med 27:882-890
42. Goti D, Hrzenjak A, Levak-Frank S, Frank S, van Der Westhuyzen DR, Malle E, Sattler W (2001) Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL-associated vitamin E. J Neurochem 76: 498-508
43. Goti D, Reicher H, Malle E, Kostner GM, Panzenboeck U, Sattler W (1998) High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles. Biochem J 332: 57-65
44. Hosomi A, Arita M, Sato Y, Kiyose C, Ueda T, Igarashi O, Arai H, Inoue K (1997) Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. FEBS Lett 409:105-108
45. Traber MG, Kayden HJ (1989) Alpha-tocopherol as compared with gamma-tocopherol is preferentially secreted in human lipoproteins. Ann N Y Acad Sci 570:95-108
46. Traber MG, Kayden HJ (1989) Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins. Am J Clin Nutr 49:517-526
47. Copp RP, Wisniewski T, Hentati F, Larnaout A, Ben Hamida M, Kayden H J (1999) Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders. Brain Res 822:80-87
48. Yokota T, Shiojiri T, Gotoda T, Arita M, Arai H, Ohga T, Kanda T, Suzuki J, Imai T, Matsumoto H, etal. (1997) Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol 41:826-832
49. Tamaru Y, Hirano M, Kusaka H, Ito H, Imai T, Ueno S (1997) Alpha-Tocopherol transfer protein gene: exon skipping of all transcripts causes ataxia. Neurology 49:584-588
50. Jishage K, Arita M, Igarashi K, Iwata T, Watanabe M, Ogawa M, Ueda O, Kamada N, Inoue K, Arai H, Suzuki H (2001) Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice. J Biol Chem 276: 1669-1672
51. Zimmer S, Stocker A, Sarbolouki MN, Spycher SE, Sassoon J, Azzi A (2000) A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization. J Biol Chem 275: 25672-25680
52. Dutta-Roy AK, Gordon MJ, Leishman DJ, Paterson BJ, Duthie GG, James WP (1993) Purification and partial characterisation of an alpha-tocopherol-binding protein from rabbit heart cytosol. Mol Cell Biochem 123:139-144
53. Dutta-Roy AK, Leishman DJ, Gordon MJ, Campbell FM, Duthie GG (1993) Identification of a low molecular mass (14.2 kDa) alpha-tocopherol-binding protein in the cytosol of rat liver and heart. Biochem Biophys Res Commun 196:1108-1112
54. Packer L, Weber SU, Rimbach G (2001) Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutrition 131:369S-373S
55. Esterbauer H, Schmidt R, Hayn M (1997) Relationships among oxidation of low-density lipoprotein, antioxidant protection, and atherosclerosis. Adv Pharmacol 38:425-456
56. Perugini C, Bagnati M, Cau C, Bordone R, Paffoni P, Re R, Zoppis E, Albano E, Bellomo G (2000) Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. II. Effects of in vivo supplementation with alpha-tocopherol. Pharmacol Res 41:67-74
57. Perugini C, Bagnati M, Cau C, Bordone R, Zoppis E, Paffoni P, Re R, Albano E, Bellomo G (2000) Distribution of lipid-soluble antioxidants in lipoproteins from healthy subjects. I. Correlation with plasma antioxidant levels and composition of lipoproteins. Pharmacol Res 41:55-65
58. Cachia O, Berma JE, Pedruzzi E, Descomps B, Gougerot-Pocidalo MA, Leger CL (1998) Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation. J Biol Chem 273:32801-32805
59. Devaraj S, Li D, Jialal I (1996) The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest 98:756-763
60. Boscoboinik D, Szewczyk A, Azzi A (1991a) Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch Biochem Biophys 286: 264-269
61. Boscoboinik D, Szewczyk A, Hensey C, Azzi A (1991b) Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase CJ Biol Chem 266: 6188-6194
62. Tasinato A, Boscoboinik D, Bartoli GM, Maroni P, Azzi A (1995) D-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc Natl Acad Sci USA 92: 12190-12194
63. Eichholzer M, Stahelin HB, Gey KF, Ludin E, Bernasconi F (1996) Prediction of male cancer mortality by plasma levels of interacting vitamins: 17-year follow-up of the prospective Basel study. Int J Cancer 66:145-150
64. Pryor AW, Cornicelli JA, Devall LJ, Tait B, Trivedi BK, Witiak DT, Wu M (1993) A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J Org Chem 58: 3521-3532
65. Devaraj S, Adams-Huet B, Fuller CJ, Jialal I (1997) Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha- tocopherol on LDL oxidation. Arterioscler Thromb Vasc Biol 17:2273-2279
66. Devaraj S, Jialal I (1996) Oxidized low-density lipoprotein and atherosclerosis. Int J Clin Lab Res 26:178-184
67. Devaraj S, Jialal I (1998) The effects of alpha-tocopherol on critical cells in atherogenesis. Curr Opin Lipidol 9: 11-15
68. Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr (1996) Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94:2434-2440
69. Kanno T, Utsumi T, Kobuchi H, Takehara Y, Akiyama J, Yoshioka T, Horton AA, Utsumi K (1995) Inhibition of stimulus-specific neutrophil superoxide generation by alpha-tocopherol. Free Radic Res 22:431-440
70. Koya D, Lee IK, Ishii H, Kanoh H, King GL (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J Am Soc Nephrol 8:426-435
71. Studer RK, Craven PA, DeRubertis FR (1997) Antioxidant inhibition of protein kinase C-signaled increases in transforming growth factor-beta in mesangial cells. Metabolism 46: 918-925
72. Tada H, Ishii H, Isogai S (1997) Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations. Metabolism 46:779-784
73. Martin-Nizard F, Boullier A, Fruchart JC, Duriez P (1998) Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells. J Cardiovasc Risk 5:339-345
74. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A (1998) Alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 334:243-249
75. Clement S, Tasinato A, Boscoboinik D, Azzi A (1997) The effect of alpha-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation. Eur J Biochem 246:745-749
76. Neuzil J, Weber C, Kontush A (2001) The role of vitamin E in atherogenesis: linking the chemical, biological and clinical aspects of the disease. Atherosclerosis 157:257-283
77. Aratri E, Spycher SE, Breyer I, Azzi A (1999) Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett 447:91-94
78. Azzi A, Boscoboinik D, Fazzio A, Marilley D, Maroni P, Ozer NK, Spycher S, Tasinato A (1998) RRR-alpha-tocopherol regulation of gene transcription in response to the cell oxidant status. Z Ernahrungswiss 37:21-28
79. Ricciarelli R, Maroni P, Ozer N, Zingg JM, Azzi A (1999) Age-dependent increase of collagenase expression can be reduced by alpha-tocopherol via protein kinase C inhibition. Free Radic Biol Med 27:729-737
80. Shaw HM, Huang C (1998) Liver alphatocopherol transfer protein and its mRNA are differentially altered by dietary vitamin E deficiency and protein insufficiency in rats. J Nutr 128: 2348-2354
81. Febbraio M, Podrez E, Smith J, Hajjar D, Hazen S, Hoff H, Sharma K, Silverstein R (2000) Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice (In Process Citation). J Clin Invest 105:1049-1056
82. Devaraj S, Hugou I, Jialal I (2001) Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages. J Lipid Res 42:521-527
83. Ricciarelli R, Zingg JM, Azzi A (2000) Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells. Circulation 102:82-87
84. Teupser D, Thiery J, Seidel D (1999) Alpha-tocopherol down-regulates scavenger receptor activity in macrophages. Atherosclerosis 144:109-115
85. Islam KN, Devaraj S, Jialal I (1998) Alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation 98:2255-2261
86. Martin A, Foxall T, Blumberg JB, Meydani M (1997) Vitamin E inhibits low-density lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro. Arterioscler Thromb Vasc Biol 17:429-436
87. Steiner M, Li W, Ciaramella JM, Anagnostou A, Sigounas G (1997). D1-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells. J Cell Physiol 172: 351-360
88. Wu D, Koga T, Martin KR, Meydani M (1999) Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes. Atherosclerosis 147:297-307
89. Yoshikawa T, Yoshida N, Manabe H, Terasawa Y, Takemura T, Kondo M (1998) Alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. Biofactors 7:15-19
90. Williams JC, Forster LA, Tull SP, Wong M, Bevan RJ, Ferns GA (1997) Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia. Int J Exp Pathol 78:259-266
91. Saldeen T, Li D, Mehta JL (1999) Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 34:1208-1215
92. Iuliano L, Mauriello A, Sbarigia E, Spagnoli LG, Violi F (2000) Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: effect of vitamin E supplementation. Circulation 101:1249-1254
93. Teupser D, Stein O, Burkhardt R, Nebendahl K, Stein Y, Thiery J (1999) Scavenger receptor activity is increased in macrophages from rabbits with low atherosclerotic response: studies in normocholesterolemic high and low atherosclerotic response rabbits. Arterioscler Thromb Vasc Biol 19: 1299-1305
94. Lee IK, Koya D, Ishi H, Kanoh H, King GL (1999) D-Alpha-tocopherol prevents the hyperglycemia induced activation of diacylglycerol (DAG)-protein kinase C (PKC) pathway in vascular smooth muscle cell by an increase of DAG kinase activity. Diabetes Res Clin Pract 45:183-190
95. Jialal I, Devaraj S, Kaul N (2001) The effect of alpha-tocopherol on monocyte proatherogenic activity. J Nutr 131: 389S-394S
96. Wu D, Hayek MG, Meydani S (2001) Vitamin E and macrophage cyclooxygenase regulation in the aged. J Nutr 131: 382S-388S